Vive la difference! For a global campaign to be truly effective, medical education and rep training needs to be translated to meet the needs of each continent, each country and even each community.(Medical Education)
Publication Date: 01-MAR-06
Publication Title: European Pharmaceutical Executive
Format: Online
Author: Dawson, Sarah ; Price, Jane

Read this article now
Try Goliath Business News - FREE!

You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description

Science and medicine are now truly international. The internet allows researchers and clinicians to access papers wherever they are and whenever they want. Conferences and meetings--even those that were once the preserve of a particular country's clinicians--now attract cosmopolitan audiences. In addition, medical education campaigns are driven increasingly from global headquarters, reflecting the international nature of publication planning, symposia production and key opinion leader development.

However, global medical education campaigns still need to be implemented locally. They still need to alter the behaviour of physicians and patients within cultures that can vary widely, even within the same country. Those programmes and campaigns that do not work with the local cultural grain risk not attaining their full potential.

Culture clashes

Despite the rise of global brands in pharmaceuticals and fast-moving consumer goods, the pervasive influence of multinational media companies, increasing European integration, Stockholm and Siena, Madrid and Manchester, Bradford and Barcelona remain very different cities. Attitudes to health and medicine across Europe reflect this diversity.

French doctors, for example, traditionally managed diseases such as spasmophile, colibaccilose and crise de foie that--notes anthropologist Daniel Moerman in Meaning, Medicine and the 'Placebo Effect' (1)--"simply don't exist elsewhere in the world." Similarly, in Germany, the rate of coronary heart disease that is broadly similar to the rest of the major markets. (1)

However, Lynn Payer in Medicine and Culture points out that the Germans traditionally use six times more cardiovascular medicines than the French or British. Furthermore, based on the conventional criteria for assessing electrocardiagrams (ECGs), German physicians decide that some 40% of patients need heart medicine. When doctors in the USA examine the same ECGs, they decide that just 5% require treatment. (2)

The reason for this discrepancy lies in...



More articles from European Pharmaceutical Executive
A new era: Lisa Roner of eyeforpharma offers a round-up of how some of..., March 01, 2006
Calls and effect: understanding how approaches to sales calls differ a..., March 01, 2006

Looking for additional articles?
Click here to search our database of over 3 million articles.